Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Thyroid hormone replacement therapy"'
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Purpose At present, the relationship between hypothyroidism and the risk of breast cancer is still inconclusive. This meta-analysis was used to systematically assess the relationship between hypothyroidism and breast cancer risk, and to asse
Externí odkaz:
https://doaj.org/article/f74d27db1f974284bb8241d87bc62314
Autor:
J.N. Kolla
Publikováno v:
Cancer Treatment and Research Communications, Vol 31, Iss , Pp 100567- (2022)
Externí odkaz:
https://doaj.org/article/4b4ca320f497428eb9de44bf06033014
Autor:
Enrique Soto-Pedre, Moneeza K. Siddiqui, Cyrielle Maroteau, Adem Y. Dawed, Alex S. Doney, Colin N. A. Palmer, Ewan R. Pearson, Graham P. Leese
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
AimsAtrial fibrillation (AF) is a risk for patients receiving thyroid hormone replacement therapy. No published work has focused on pharmacogenetics relevant to thyroid dysfunction and AF risk. We aimed to assess the effect of L-thyroxine on AF risk
Externí odkaz:
https://doaj.org/article/5c6ce436a3ce49038c91e9faed6d699c
Autor:
Olutomiwa Omokore, Nwachukwu Nwachukwu, Oreoluwa Fuwape, Adetomilayo Arijeniwa, Abiola Adekoya, Akolade Idowu
Publikováno v:
Babcock University Medical Journal, Vol 4, Iss 1 (2021)
Background: Primary hypothyroidism can lead to hyperprolactinemia through several mechanisms in both men and women, manifesting as galactorrhoea, loss of libido, and infertility in both sexes, as oligomenorrhea/amenorrhea in women, and as gynecomasti
Externí odkaz:
https://doaj.org/article/834346dbdc8f426fbf6e4012fe5fe079
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A.M. Kvacheniuk, D.A. Kvacheniuk
Publikováno v:
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 14:268-271
Clinical and subclinical hypothyroidism are the one of the most common pathologies in the practice of endocrinologist after type 2 diabetes mellitus. Each year, in up to 5 % of patients, latent (subclinical) hypothyroidism changes to clinical. Despit
Autor:
Javier Malcolm Barney, Fabiola Valenzuela, Candace Robledo, Henry A. Reinhart, Samuel K. Snyder, Luis Berrios, Minerva A. Romero Arenas
Publikováno v:
Journal of Surgical Research. 264:316-320
Background Current thyroid hormone replacement therapy (THRT) is built on weight-based standard calculation of dose. A novel Poisson regression model, which accounts for seven clinical variables, was recently proposed to improve accuracy of THRT. We
Autor:
Boseok Cha, Young-Ji Lee, So-Jin Lee, Dongyun Lee, Jae-Won Choi, Ji-Yeong Seo, Jin Woo Oh, Soo Kyoung Kim, Youn Jung Lee, Jae-Hon Lee, Cheol-Soon Lee, Bong-Jo Kim, Myung-Hee Kang
Publikováno v:
Chronobiology in Medicine. 2:129-133
Publikováno v:
Clinical Endocrinology. 93:196-203
Depressive mood consequent to hypothyroidism can be reversed with levothyroxine (LT4) replacement therapy. However, it is unclear whether increasing LT4 dose confers additional mood benefits.A single-blinded before-and-after study of 24 patients with
Publikováno v:
Endocrine
Purpose Hemithyroidectomy is a valid operation to retain functional contralateral thyroid lobe that is indicated for a variety of thyroid diseases. This study aimed at determination of the risk factors for thyroid hormone replacement following hemith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e803497189da80f1759578c9550ba0a8
https://doi.org/10.21203/rs.3.rs-1026434/v1
https://doi.org/10.21203/rs.3.rs-1026434/v1